FDA Inspection 1324328 — Merck & Cie
The FDA completed an inspection of Merck & Cie on March 7, 2024 in Altdorf Ur. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 7, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Altdorf Ur (Switzerland)
Additional Details
Mutual Recognition Agreement (MRA)